APA

Balazuc A. M., Lagranderie M., Chavarot P., Pescher P., Roseeuw E., Schacht E., Domurado D. & Marchal G. (20050921). In vivo efficiency of targeted norfloxacin against persistent, isoniazid-insensitive, Mycobacterium bovis BCG present in the physiologically hypoxic mouse liver. : Microbes and infection.

Chicago

Balazuc A M, Lagranderie M, Chavarot P, Pescher P, Roseeuw E, Schacht E, Domurado D and Marchal G. 20050921. In vivo efficiency of targeted norfloxacin against persistent, isoniazid-insensitive, Mycobacterium bovis BCG present in the physiologically hypoxic mouse liver. : Microbes and infection.

Harvard

Balazuc A. M., Lagranderie M., Chavarot P., Pescher P., Roseeuw E., Schacht E., Domurado D. and Marchal G. (20050921). In vivo efficiency of targeted norfloxacin against persistent, isoniazid-insensitive, Mycobacterium bovis BCG present in the physiologically hypoxic mouse liver. : Microbes and infection.

MLA

Balazuc A M, Lagranderie M, Chavarot P, Pescher P, Roseeuw E, Schacht E, Domurado D and Marchal G. In vivo efficiency of targeted norfloxacin against persistent, isoniazid-insensitive, Mycobacterium bovis BCG present in the physiologically hypoxic mouse liver. : Microbes and infection. 20050921.